• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6,191
2,045
1,970
1,632
1,446

COUNTRY

996
795
249
216
175

CATEGORIES

  • 933
  • 177
  • 113
  • 322
    • 55
  • 468
  • 237
  • 237
  • 47
  • 67
  • 799
  • 1,425
  • 840
  • 17
  • 444
  • 1,362
  • 2,287
    • 82
    • 121
    • 66
    • 66
    • 36
    • 37
    • 12
    • 11
    • 12
    • 18
  • 23
  • 260
  • 44

PRICE

5,701
12,879
20,407
25,785

PUBLISHED

3,807
5,145
10,137
25,785

PRODUCT TYPE

21,648
1,955
1,006
910
164
38
21
19
17
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015 Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Gastric Cancer patient population study in a new report ‘Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015 Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Cervical Cancer patient population study in a new report ‘Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights...

January 2015
FROM
Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015 Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Head and Neck Cancer patient population study in a new report ‘Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides...

January 2015
FROM
Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015 Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Bladder Cancer patient population study in a new report ‘Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015 Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Ovarian Cancer patient population study in a new report ‘Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015 Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Breast Cancer patient population study in a new report ‘Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
2015 Global Infectious Disease Market Outlook: Facilities, Test Volume, and Sales Forecasts by Country 2015 Global Infectious Disease Market Outlook: Facilities, Test Volume, and Sales Forecasts by Country - Product Thumbnail Image

2015 Global Infectious Disease Market Outlook: Facilities, Test Volume, and Sales Forecasts by Country

This report provides a worldwide overview of the infectious disease testing market environment, structure, size and growth. Includes estimates of the number of laboratories performing infectious disease...

January 2015
FROM
2015 Global Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country 2015 Global Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country - Product Thumbnail Image

2015 Global Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories...

January 2015
FROM
2015 World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants 2015 World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants - Product Thumbnail Image

2015 World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological...

January 2015
FROM
Fierce 15 in Oncology Drug Pipeline Update 2015 Fierce 15 in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

Fierce 15 in Oncology Drug Pipeline Update 2015

The prestigious Fierce 15 biotech award has come to symbolize novelty and being at the forefront of biotechnology development amongst privately held businesses. The winners of this award are aiming...

January 2015
FROM
CAR-T Therapies in Oncology Drug Pipeline Update 2015 CAR-T Therapies in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

CAR-T Therapies in Oncology Drug Pipeline Update 2015

Chimeric antigen receptors (CARs) are a game changer within cancer therapies and there will be a place in history and huge recognition for any company which is able to launch the first successful CAR-T...

January 2015
FROM
Ovarian Cancer Drug Pipeline Update 2015 Ovarian Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Ovarian Cancer Drug Pipeline Update 2015

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for...

January 2015
FROM
Liver Cancer Drug Pipeline Update 2015 Liver Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Liver Cancer Drug Pipeline Update 2015

There are today 183 companies plus partners developing 219 drugs targeting liver cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last...

January 2015
FROM
Immunotherapy in Oncology Drug Pipeline Update 2015 Immunotherapy in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

Immunotherapy in Oncology Drug Pipeline Update 2015

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update the author brings together...

January 2015
FROM
Pancreatic Cancer Drug Pipeline Update 2015 Pancreatic Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Pancreatic Cancer Drug Pipeline Update 2015

There are today 291 companies plus partners developing 347 drugs targeting pancreatic cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the...

January 2015
FROM
Lung Cancer Drug Pipeline Update 2015 Lung Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Lung Cancer Drug Pipeline Update 2015

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D...

January 2015
FROM
Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2015 Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2015

The Alpha6 Beta4 Integrin signaling pathway activates the PI 3-kinase/Akt, MAPK/NFkB and SMAD signaling modules. There are today 267 companies plus partners developing 353 Alpha6Beta4 integrin pathway...

January 2015
FROM
Colorectal Cancer Drug Pipeline Update 2015 Colorectal Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Colorectal Cancer Drug Pipeline Update 2015

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of...

January 2015
FROM
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015 Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 343 companies plus partners developing 401 Androgen Receptor drugs in 1537 developmental projects in cancer....

January 2015
FROM
Cancer Vaccines Drug Pipeline Update 2015 Cancer Vaccines Drug Pipeline Update 2015 - Product Thumbnail Image

Cancer Vaccines Drug Pipeline Update 2015

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit...

January 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S